GlobeNewswire Inc. · Sep 8, 2023
Advanced Health Intelligence Ltd Signs Collaboration Agreement with Bin Farhood International Business Management Group L.L.C
Highlights
AH
NASDAQ · AHI
Advanced Health Intelligence Ltd
Technology · Software - Application
$1.50
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 5:01 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 345.76M
- P/E ratio
- -5.65
- Dividend yield
- 0.00%
- 52-week range
- $0.64 – $15.52
- Volume
- 12.2K
- Avg. volume
- 196
Price performance
AHI price history
1M range · 0 trading sessions · Daily adjusted prices
AHI does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest AHI news
The latest Smart Investors Daily articles mentioning AHI.
Stock researchCompany · Overview
AHI research
Overview
Company profile and research snapshot.
Company profile
Advanced Health Intelligence Ltd operates as a mobile application and technology development company in Australia and internationally. It develops and patents BodyScan, a proprietary measurement/dimensioning technology that enables end-user to check and assess body dimensions using a smartphone. The company also provides FaceScan for measuring vital signs, and risks associated with cardiovascular disease, heart attack, and stroke; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 29, 2023
Advanced Health Intelligence Ltd Announces Implementation of ADS Ratio Change
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”) announces today that its planned ratio change of the Company’s American Depositary Shares (ADSs) to its non-traded ordinary shares from the previous ratio of one (1) ADS representing seven (7) ordinary shares to the new ratio of one (1) ADS representing twenty-eight (28) ordinary shares shall become effective on June 30, 2023. The ratio change will have the same effect as a reverse split of the existing ADSs of 1 new ADS for every 4 old ADSs. The effective date for the ratio change is June 29, 2023, and the Company’s ADSs will continue to be traded on the Nasdaq Capital Market (“Nasdaq”) under the symbol “AHI” with a new CUSIP Number 00777C 203.
PennyStocks · Jun 10, 2023
These Are the Top Swing Trading Penny Stocks Strategies in 2023
Use these swing trading strategies for penny stocks in 2023 The post These Are the Top Swing Trading Penny Stocks Strategies in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Jun 9, 2023
Best Penny Stocks To Buy? 3 To Watch Before Next Week
Are these top penny stocks to buy after recent milestones? The post Best Penny Stocks To Buy? 3 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
